Haemonetics's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Haemonetics in the second quarter 2026?
Haemonetics Corporation achieved a return on average equity (ROE) of 12.07 % in its second quarter 2026, this is above HAE's average return on equity of 7.7%.
Haemonetics Corporation shareholder's equity over the 12 months ending in its second quarter 2026 are valued at $861 million

ROE has advanced compared to 11.35% in the first quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry 32 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 1238, from total ROE ranking in the first quarter 2026 at 1262.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 26 2026) II. Quarter	(Jun 27 2026) I. Quarter	(Mar 28 2026) IV. Quarter	(Dec 27 2025) III. Quarter	(Sep 27 2025) II. Quarter
Y / Y Equity Change	5.81 %	-5.12 %	-2.99 %	0.51 %	-
Y / Y Net Income Change	19.7 %	-3 %	-	19.33 %	14.34 %
Net Income (TTM) in Millions	104	96	97	175	168
Return On Equity (TTM)	12.07 %	11.35 %	11.32 %	20.26 %	19.45 %
HAE's Total Ranking	# 1238	# 1262	# 113	# 562	#
Equity (TTM) in Millions	898	837	796	911	849
Seq. Equity Change	7.33 %	5.12 %	-12.63 %	7.33 %	-3.75 %
Seq. Net Income Change	40.28 %	-	-	15.66 %	13.67 %

Back to HAE Management Effectiveness >> HAE's 5 Years Annual ROE >> Compare HAE ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 33
Sector	# 123
Overall	# 1238

Return On Equity Statistics
High	Average	Low
20.26 %	7.7 %	-8.64 %
(Dec 27 2025)		(Jul 02 2016)

HAE Annual Return On Equity	(Mar 28 2026) 2026	(Mar 29 2025) 2025	(Mar 30 2024) 2024	(Apr 01 2023) 2023	(Apr 02 2022) 2022
Total Equity in Millions	796	821	960	818	749
Y / Y Equity Change	-2.99 %	-14.49 %	17.35 %	9.15 %	2.43 %
Net Income in Millions	97	168	118	115	43
Y / Y Net Income Change	-41.97 %	42.64 %	1.87 %	166.05 %	-45.42 %
Return On Equity	12.22 %	20.43 %	12.25 %	14.11 %	5.79 %

Back to HAE Management Effectiveness >> HAE's 5 Years Annual ROE >> Compare HAE ROE to its Competitors

Annual Roe Comment

In 2026 ROE decreased compared to the previous year to 12.22 %, due to deterioration of net income.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HAE's' Return on Equity at Yahoo Finance
HAE's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for HAE's Competitors
Subscribers only: Roe for Haemonetics's Suppliers
Subscribers only: Return On Equity for HAE's Customers

Companies with similar Return On Equity at Sep 26 2026, within Healthcare Sector	ROE
Chemed Corporation	32.10 %
Illumina Inc	31.45 %
Transmedics Group Inc	28.74 %
Acadia Pharmaceuticals Inc	28.03 %
Pro dex Inc	26.91 %
Sotera Health Company	26.41 %
Pacs Group Inc	25.65 %
Standard Biotools Inc	25.58 %
Resmed Inc	25.50 %
Bioventus Inc	24.60 %
Encompass Health Corporation	24.08 %
Iradimed Corporation	23.90 %
Corcept Therapeutics Inc	22.88 %
Msa Safety Inc	21.79 %
Lantheus Holdings Inc	21.72 %
Iqvia Holdings Inc	21.40 %
Denali Therapeutics Inc	21.40 %
West Pharmaceutical Services Inc	21.08 %
Brightspring Health Services Inc	20.31 %
Healthcare Services Group Inc	20.22 %
Vertex Pharmaceuticals Inc	20.08 %
Ge Healthcare Technologies Inc	20.04 %
Neurocrine Biosciences Inc	19.74 %
Ani Pharmaceuticals Inc	19.70 %
Johnson and Johnson	19.55 %
Beone Medicines Ltd	18.21 %
Pediatrix Medical Group Inc	17.28 %
Kiniksa Pharmaceuticals International Plc	17.27 %
Krystal Biotech Inc	17.02 %
Intuitive Surgical Inc	16.99 %

Date modified: 2026-11-08T19:25:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.